Literature DB >> 8702782

Critical residues for ligand binding in an I domain-like structure of the integrin beta1 subunit.

W Puzon-McLaughlin1, Y Takada.   

Abstract

Several integrin alpha subunits have an inserted sequence of about 200 residues (the I or A domain) that is critical for ligand interactions. The presence of an I domain-like structure within the integrin beta subunit has been proposed based on the similarity of the hydropathy profiles and the homology of sequences between the alpha and beta subunits. This study was designed to determine whether the region of the beta1 subunit that includes residues 101-335 has the characteristics of an I domain. We found novel critical residues for ligand binding (Ser-132, Asn-224, Asp-226, Glu-229, Asp-233, Asp-267, and Asp-295, in addition to the previously reported Asp-130) using site-directed mutagenesis. The critical residues for ligand binding are located in several of loop structures of the region (or in a potential loop between an alpha helix and a beta strand), which have been predicted using multiple secondary structure prediction methods. The data suggest that the beta subunit has multiple disrupted critical oxygenated residues for ligand binding similar to those found in the alpha I domain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702782     DOI: 10.1074/jbc.271.34.20438

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Role of altered sialylation of the I-like domain of beta1 integrin in the binding of fibronectin to beta1 integrin: thermodynamics and conformational analyses.

Authors:  Di Pan; Yuhua Song
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

2.  Molecular evolution of integrins: genes encoding integrin beta subunits from a coral and a sponge.

Authors:  D L Brower; S M Brower; D C Hayward; E E Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Identification of integrin beta subunit mutations that alter affinity for extracellular matrix ligand.

Authors:  Timmy Kendall; Leona Mukai; Alison L Jannuzi; Thomas A Bunch
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

4.  A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysis.

Authors:  Tony J You; David S Maxwell; Timothy P Kogan; Qi Chen; Jian Li; Jamal Kassir; George W Holland; Richard A F Dixon
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 5.  Cell adhesion in vascular biology. New insights into integrin-ligand interaction.

Authors:  J C Loftus; R C Liddington
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1.

Authors:  A P Mould; A N Garratt; W Puzon-McLaughlin; Y Takada; M J Humphries
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

7.  Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen.

Authors:  Maciej J Stawikowski; Beatrix Aukszi; Roma Stawikowska; Mare Cudic; Gregg B Fields
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

8.  Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains.

Authors:  Q Chen; Y Zhang; D M Johnson; P F Goetinck
Journal:  Mol Biol Cell       Date:  1999-07       Impact factor: 4.138

Review 9.  Platelet integrin alphaIIbbeta3-ligand interactions: what can we learn from the structure?

Authors:  T Kamata; Y Takada
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

10.  A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1.

Authors:  N Hogg; M P Stewart; S L Scarth; R Newton; J M Shaw; S K Law; N Klein
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.